Juvena Therapeutics | Biopharma | Standout | Standout

Juvena Therapeutics

2 employees

Biopharma

Series B · $86.3M

Company details

Team Size2

IndustryBiopharma

Funding

Total raised

$86.3M

Last stage

Series B

Investors

Bison Ventures

Mubadala Capital

Horizons Ventures

StandoutYBacked by Y Combinator · P26

“LeBron has an agent. Why don’t you?”

— Now you have one too.

Earn $3,000

ProductHow it works For talent For companies Browse jobs Browse companies

CompanyAbout Blog Careers

ConnectTwitter / X LinkedIn

Standout.

Privacy Terms

Eli Lilly

Manta Ray Ventures

Founders

Hanadie Yousef

Scientist-turned-entrepreneur and global thought leader in AI-driven regenerative medicine. PhD from UC Berkeley (Molecular & Cell Biology), postdoctoral fellow at Stanford. Co-founded Juvena in 2017; served as CEO, CFO, and Board Chair through 2025.

Jeremy O'Connell

Chief Scientific Officer overseeing research strategy, pre-clinical science, manufacturing, and IP. PhD from UT Austin, postdoctoral fellowship at Harvard Medical School (Steven Gygi lab). Expertise in proteomics, systems biology, and machine learning.

What happens next.

No applications, no recruiter spam. Just the intro.

Confirm the fit

A few questions to make sure this role is the right shape for you. Two minutes.

I pitch you to the company

I write the intro, send it to the founder, and handle the back-and-forth.

A meeting lands on your calendar

If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.